Source: biocare medical Blog

biocare medical Blog FISH and Cytogenetic Analysis: Probing for CLL and MDS

Fluorescence in situ hybridization (FISH) probes have become a cornerstone of cytogenetic analysis in hematological malignancies. These targeted probes allow for the detection of specific chromosomal abnormalities associated with various leukemias and myelodysplastic syndromes (MDS). This white paper will explore the importance of FISH probes for Chronic Lymphocytic Leukemia (CLL) and Myelodysplastic Syndromes (MDS)The post FISH and Cytogenetic Analysis: Probing for CLL and MDS appeared first on Biocare Medical.

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Luis de Luzuriaga's photo - CEO of Biocare Medical

CEO

Luis de Luzuriaga

CEO Approval Rating

90/100

Read more